Progress in antibody arrays.

Arrays of antibodies and of other types of ligand-binding molecule (e.g. protein scaffolds or aptamers) provide a means for rapid detection of proteins and other analytes in multiple samples and ultimately for screening the human proteome in health and disease. The chief reasons for using an array-based approach to diagnostics and proteomics relate to the advantages associated with parallelisation, miniaturisation and automation. The current generation of antibody microarrays promises to perform well as diagnostic tools and for limited protein profiling, using relatively small numbers of available antibodies. Sensitivity, specificity and signal-to-noise ratios in the multiplex format are major issues and will become more critical as the complexity of arrays is increased. This review describes progress in solving problems associated with the construction of antibody arrays.

[1]  A. Karlström,et al.  Dual labeling of a binding protein allows for specific fluorescence detection of native protein. , 2001, Analytical biochemistry.

[2]  S. Kingsmore,et al.  Multiplexed protein profiling on microarrays by rolling-circle amplification , 2002, Nature Biotechnology.

[3]  M. Taussig,et al.  DiscernArray technology: a cell-free method for the generation of protein arrays from PCR DNA. , 2003, Journal of immunological methods.

[4]  R. Christopherson,et al.  Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. , 2001, Cancer research.

[5]  E. B. Butler,et al.  Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers , 2003, Proteomics.

[6]  Gavin MacBeath,et al.  Protein microarrays and proteomics , 2002, Nature Genetics.

[7]  George Georgiou,et al.  Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. , 2002, Nucleic acids research.

[8]  M. Snyder,et al.  Protein chip technology. , 2003, Current opinion in chemical biology.

[9]  D. Figeys,et al.  Proteomics on a chip: Promising developments , 2001, Electrophoresis.

[10]  J. Desmet,et al.  Development and application of cytotoxic T lymphocyte‐associated antigen 4 as a protein scaffold for the generation of novel binding ligands , 2000, FEBS letters.

[11]  Larry Gold,et al.  Dimensionality is the issue: use of photoaptamers in protein microarrays. , 2002, Current opinion in biotechnology.

[12]  R. Christopherson,et al.  Antibody arrays: an embryonic but rapidly growing technology. , 2002, Drug discovery today.

[13]  Jonas Jarvius,et al.  A sense of closeness: protein detection by proximity ligation. , 2003, Current opinion in biotechnology.

[14]  T. Barrette,et al.  Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. , 2001, Cancer research.

[15]  P. Lizardi,et al.  Mutation detection and single-molecule counting using isothermal rolling-circle amplification , 1998, Nature Genetics.

[16]  A. Lim,et al.  Directed evolution of high-affinity antibody mimics using mRNA display. , 2002, Chemistry & biology.

[17]  M. Uhlén,et al.  Ligands selected from combinatorial libraries of protein A for use in affinity capture of apolipoprotein A-1M and taq DNA polymerase. , 2000, Journal of biotechnology.

[18]  J. Hoheisel,et al.  Antibody microarrays: promises and problems. , 2002, BioTechniques.

[19]  P. Cutler.  Protein arrays: The current state‐of‐the‐art , 2003, Proteomics.

[20]  J C Cox,et al.  Automated selection of anti-protein aptamers. , 2001, Bioorganic & medicinal chemistry.

[21]  L. Liotta,et al.  Proteomic profiling of the cancer microenvironment by antibody arrays , 2001, Proteomics.

[22]  Rick Wiese,et al.  Simultaneous analysis of eight human Th1/Th2 cytokines using microarrays. , 2002, JIM - Journal of Immunological Methods.

[23]  M. Uhlén,et al.  Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain , 1997, Nature Biotechnology.

[24]  J. Power,et al.  Strategies for signal amplification in nucleic acid detection , 2001, Molecular biotechnology.

[25]  H. Lehrach,et al.  Toward optimized antibody microarrays: a comparison of current microarray support materials. , 2002, Analytical biochemistry.

[26]  P. Brown,et al.  Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions , 2001, Genome Biology.

[27]  T. Chang,et al.  Binding of cells to matrixes of distinct antibodies coated on solid surface. , 1983, Journal of immunological methods.

[28]  J. Hoheisel,et al.  Antibody microarrays: An evaluation of production parameters , 2003, Proteomics.

[29]  E. Ballestar,et al.  Methyl-CpG-binding proteins. Targeting specific gene repression. , 2001, European journal of biochemistry.

[30]  L. Gold,et al.  Aptamers as therapeutic and diagnostic agents. , 2000, Journal of biotechnology.

[31]  P. Nordlund,et al.  Structural basis for recognition by an in vitro evolved affibody , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Peluso,et al.  Optimizing antibody immobilization strategies for the construction of protein microarrays. , 2003, Analytical biochemistry.

[33]  M. Taussig,et al.  Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). , 2001, Nucleic acids research.

[34]  A. Mirzabekov,et al.  Protein microchips: use for immunoassay and enzymatic reactions. , 2000, Analytical biochemistry.

[35]  A. Skerra.  'Anticalins': a new class of engineered ligand-binding proteins with antibody-like properties. , 2001, Journal of biotechnology.

[36]  M. Uhlén,et al.  Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A. , 2001, European journal of biochemistry.

[37]  U. Landegren,et al.  Protein detection using proximity-dependent DNA ligation assays , 2002, Nature Biotechnology.

[38]  D. Cahill,et al.  Protein and antibody arrays and their medical applications. , 2001, Journal of immunological methods.

[39]  R. Ladner,et al.  Novel frameworks as a source of high-affinity ligands. , 2001, Current opinion in biotechnology.

[40]  Ronald W. Davis,et al.  Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar–coding strategy , 1996, Nature Genetics.